InsidersTradesSigma
Follow the 宁科生物 share price and the full directors' dealings record of the company, a listed issuer based in China. Shares are listed on the CN market, under the supervision of SSE / SZSE (CSRC). The latest transaction was disclosed on 3 September 2026 (Purchase). Among the most active insiders: 王炜. The full history is free.
This score ranks the purchase within its own market. No market currently meets the historical allocation criteria, so signals remain watch-only. Not investment advice.
Fundamental view, insider signal, bull and bear case, synthesis.
AI analysis generation is paused.
宁科生物 is a biotechnology company focused on developing innovative health solutions. It is listed on the Shanghai Stock Exchange.